Do hemostatic agents affect shear bond strength and clinical bond failure rate of orthodontic brackets?

Basit Öğe Kaydı
dc.contributor.authorKarabekiroglu, Said
dc.contributor.authorKok, Hatice
dc.date.accessioned2024-02-23T14:17:15Z
dc.date.available2024-02-23T14:17:15Z
dc.date.issued2018
dc.departmentNEÜen_US
dc.description.abstractTo evaluate the effects of different hemostatic agents on the shear bond strength (SBS) in vitro and clinical bond failure rate of orthodontic metal brackets in vivo. A total of 100 human premolar teeth were randomly divided into five groups: control, blood, Viscostat, hydrogen peroxide (H2O2), and epinephrine. Teeth were bonded with same light-cured adhesive and composite. After storage in distilled water for 24h, thermal cycling was used as an aging procedure on all samples. The brackets were subjected to an SBS test at a speed of 0.5mm/min until bracket debonding. SBS values and the adhesive remnant index were evaluated. Ninety-nine patients (52 female, 47 males) undergoing routine orthodontic treatment were recruited for this controlled clinical study at bonding stages. All patients with bleeding on the buccal surface of any premolar tooth or teeth at bonding were included in this study. Over 6months, the bond failure rate was calculated. Data were analyzed using one-way analysis of variance (ANOVA) and Tukey's post-hoc test (p<.05). The McNemar test was used to compare bracket-bond failure. ANOVA showed a significant difference (p<.001) between the groups. No significant differences were found between the hemostatic agent groups (p>0.05) in the in vitro part. The lowest failure rate was obtained in the control group rather than the hemostatic agent groups during clinical follow-up (p<0.05). Each of the hemostatic agents (Viscostat, H2O2, and epinephrine) can be used for bleeding management during the orthodontic bonding process. Epinephrine application showed a high bond-failure rate at clinical follow-up.en_US
dc.identifier.doi10.1080/01694243.2017.1333201
dc.identifier.endpage113en_US
dc.identifier.issn0169-4243
dc.identifier.issn1568-5616
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85019666397en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage103en_US
dc.identifier.urihttps://doi.org/10.1080/01694243.2017.1333201
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13021
dc.identifier.volume32en_US
dc.identifier.wosWOS:000414215800008en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofJournal Of Adhesion Science And Technologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBond Failureen_US
dc.subjectShear-Bond-Strengthen_US
dc.subjectHemostatic Agenten_US
dc.titleDo hemostatic agents affect shear bond strength and clinical bond failure rate of orthodontic brackets?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu